Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Feb 22 2021

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 22, 2021, titled "Glenmark s Ryaltris��‐ innovative single nasal spray, ready to market in Russia".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases